| | | | | | | |
 | CSL LIMITED | 1.55% | 0.43% | -1.37% | -2.63% | 22.38% | 88 263 |
 | BIOGEN INC. | -3.76% | 38.76% | 10.96% | -6.78% | 14.34% | 40 140 |
 | SAMSUNG BIOLOGICS CO.,LTD. | 6.00% | 5.58% | -9.97% | -6.66% | 161.00% | 38 103 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -1.34% | -0.10% | -48.46% | -62.02% | 81.60% | 26 271 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 3.35% | 2.62% | -29.98% | -45.10% | 82.00% | 18 759 |
| BIOMARIN PHARMACEUTICAL INC. | -1.53% | 0.85% | -4.32% | 10.08% | 25.42% | 15 921 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -0.33% | 2.40% | -23.66% | -25.46% | --.--% | 14 724 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -0.75% | 4.51% | -15.00% | -28.23% | --.--% | 8 886 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 1.07% | -1.94% | -34.31% | -43.98% | 34.11% | 8 142 |
| CELLTRION HEALTHCARE CO., LTD. | 3.90% | 3.90% | -16.96% | -38.69% | 42.66% | 6 940 |
| APELLIS PHARMACEUTICALS, INC. | 4.10% | 0.16% | 38.71% | 93.28% | 172.23% | 6 922 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 2.05% | -0.19% | 15.45% | -9.83% | 41.66% | 5 532 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | 2.87% | 2.87% | -56.72% | -35.64% | -15.77% | 5 448 |
 | GRIFOLS, S.A. | -2.73% | -21.16% | -47.65% | -59.33% | -67.33% | 5 359 |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | 0.19% | -0.37% | -21.99% | -23.12% | -32.14% | 4 971 |
| | | | | | | |
| | Gemiddelde | 0.98% | 2.55% | -16.35% | -18.94% | 43.24% | |
| | Gewogen gemiddelde per kap. | 0.96% | 6.30% | -10.75% | -14.81% | 52.30% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
